You Are Here:
This topic is in the process of being updated. Please go to the Update in Progress section to see the latest documents available.
This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on screening for depression in children and adolescents.
Release Date: March 2009
- The USPSTF recommends screening for major depressive disorder (MDD) in adolescents (ages 12 to 18 years) when systems are in place to ensure accurate diagnosis, psychotherapy (cognitive-behavioral or interpersonal), and followup.
Grade: B recommendation.
- The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for MDD in children (ages 7 to 11 years).
Grade: I statement.
Update in Progress
In an effort to make the USPSTF recommendations clearer and its processes more transparent, the Task Force is sharing drafts of its draft Research Plans, Evidence Reports, and Recommendation Statements for public comment. As a result, the final Recommendation Statement is not yet available.
USPSTF members work with researchers from an independent Evidence-based Practice Center (EPC) to create a Research Plan that guides the systematic review of the evidence. The Research Plan consists of an analytic framework, key questions, and a literature search strategy or research approach.
|Research Plan||Public Comment Period|
|Draft Research Plan for Public Comment||May 30–June 26, 2013|
Current as of May 2013
Screening for Major Depressive Disorder in Children and Adolescents, Topic Page. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspschdepr.htm